| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/15/2009 | CA2692783A1 Quinazolinone t-type calcium channel antagonists |
| 01/15/2009 | CA2692781A1 Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof |
| 01/15/2009 | CA2692776A1 Hydrogen chloride salt of a substituted 5-oxazol-2-yl-quinoline compound and a process for the production thereof |
| 01/15/2009 | CA2692725A1 Compound - 946 |
| 01/15/2009 | CA2691880A1 Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1h-pyrazol-4-yl)methanone |
| 01/14/2009 | EP2014658A1 Nicotinamide derivatives and method for their manufacture |
| 01/14/2009 | EP2014656A2 New heteocyclic h3 antagonists |
| 01/14/2009 | EP2014653A1 Novel dicarboxylic acid derivatives as S1P1 receptor agonists |
| 01/14/2009 | EP2014168A1 Insecticidal heterocyclic compounds |
| 01/14/2009 | EP2013204A2 2-aminopyridine analogs as glucokinase activators |
| 01/14/2009 | EP2013202A1 Substituted pyrazinone derivatives for use as a medicine |
| 01/14/2009 | EP2013201A1 Heterocyclic gpcr agonists |
| 01/14/2009 | EP2013180A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 01/14/2009 | EP1258484B1 Novel isoxazole and thiazole compounds and use thereof as drugs |
| 01/14/2009 | CN101346372A Aryl-isoxazolo-4-yl-oxadiazole derivatives |
| 01/14/2009 | CN101346370A PDF inhibitors |
| 01/14/2009 | CN101346369A Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 01/14/2009 | CN101346360A Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof |
| 01/14/2009 | CN101346358A Estrogen modulators |
| 01/14/2009 | CN101346353A Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 01/14/2009 | CN101346349A Process for the production of ezetimibe and intermediates used in this proces |
| 01/14/2009 | CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors |
| 01/13/2009 | US7478376 Computer program code size partitioning method for multiple memory multi-processing systems |
| 01/13/2009 | US7476742 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | US7476685 Pyridine carboxamide derivatives and their use as pesticides |
| 01/13/2009 | US7476684 Compounds for the treatment of neurological, psychiatric or pain disorders |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | US7476682 N-substituted piperidine derivatives as serotonin receptor agents |
| 01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 01/13/2009 | US7476669 Immobilization of taxane; anticancer, antitumor agents |
| 01/13/2009 | US7476666 HIV integrase inhibitors |
| 01/13/2009 | US7476663 Substituted thiophene carboxamides |
| 01/13/2009 | CA2216542C 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity |
| 01/08/2009 | WO2009006404A2 Heterocyclic compounds useful as raf kinase inhibitors |
| 01/08/2009 | WO2009006389A2 Pyrimidine derivatives useful as raf kinase inhibitors |
| 01/08/2009 | WO2009005729A1 Gamma secretase modulators |
| 01/08/2009 | WO2009005269A2 Pharmaceutical composition for preventintion and treatment of restenosis comprising isoxazole derivatives |
| 01/08/2009 | WO2009005076A1 Amide compound |
| 01/08/2009 | WO2009005015A1 Substituted isoxazoline or enone oxime compound, and pest control agent |
| 01/08/2009 | WO2009004650A1 Novel substituted piperidones as hsp inducers |
| 01/08/2009 | WO2009004430A1 N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors |
| 01/08/2009 | WO2009004383A2 Aza-bicyclohexane compounds useful as anticoagulants |
| 01/08/2009 | WO2009003998A2 Antiproliferative compounds based on 5-membered heterocycles |
| 01/08/2009 | WO2008141462A9 Novel case of renin inhibitors |
| 01/08/2009 | WO2008127275A3 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof |
| 01/08/2009 | WO2008100867A3 Novel inhibitors hepatitis c virus replication |
| 01/08/2009 | WO2008074450A3 Non-peptidic renin inhibitors nitroderivatives |
| 01/08/2009 | WO2008057254A3 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 01/08/2009 | US20090012291 Serotonin receptor agonists: 1-(2-aminoalkyl)-1H-furo(2,3-g)indazoles, e.g.,N-(3-hydroxy-2,2-dimethylpropyl)-1-((S)-2-aminopropyl)-1H-furo[2,3-g]indazole-7-carboxamide |
| 01/08/2009 | US20090012290 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 01/08/2009 | US20090012125 Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them |
| 01/08/2009 | US20090012123 Protective Agent for Retinal Neuronal Cell Comprising Indazole Derivative as Active Ingredient |
| 01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012089 Oxazolidinone Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators |
| 01/08/2009 | US20090012087 New Aza-Bicyclohexane Compounds Useful As Inhibitors Of Thrombin |
| 01/08/2009 | US20090012084 7-Ethoxy-4-[(2-fluoro-4-methyl-phenyl)amino]-6-(4-methylpiperazin-1-yl)cinnoline-3-carboxamide, having colony stimulating factor 1 receptor (CSF-1R) kinase inhibitory activity, used as anticarcinogenic agents |
| 01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012082 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 01/08/2009 | US20090012080 Sirtuin modulating compounds |
| 01/08/2009 | US20090012079 Triazolopyridine Compounds |
| 01/08/2009 | US20090012078 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/08/2009 | US20090012076 Tyrosine kinase inhibitors |
| 01/08/2009 | US20090012075 Fluorinated Arylamide Derivatives |
| 01/08/2009 | US20090012073 N-aroyl cyclic amines |
| 01/08/2009 | US20090012070 Pesticidal heterocycles |
| 01/08/2009 | US20090012069 Novel Antidiabetic Compounds |
| 01/08/2009 | US20090012065 Therapeutic applications of pro-apoptotic benzodiazepines |
| 01/08/2009 | US20090012062 Novel Substituted Pyrazinone Derivatives for Use in Mch-1 Mediated Diseases |
| 01/08/2009 | US20090012060 Antitumor Agent |
| 01/08/2009 | US20090012055 Piperidine derivatives such as 4-{4-[3-(2-Methoxybenzyloxy)propoxy]phenyl}-3-[3-methoxy-5-(3-methoxypropoxy)benzyloxy]piperidine, suitable as renin inhibitors, used for the treatment of hypertension, heart failure, glaucoma, cardiac infarction, kidney failure or restenosis; improved pharmacokinetics |
| 01/08/2009 | CA2695031A1 Novel substituted piperidones as hsp inducers |
| 01/08/2009 | CA2694284A1 Heterocyclic compounds useful as raf kinase inhibitors |
| 01/08/2009 | CA2693182A1 Compounds useful as raf kinase inhibitors |
| 01/08/2009 | CA2692379A1 Antiproliferative compounds based on 5-membered heterocycles |
| 01/08/2009 | CA2692265A1 Amide compounds |
| 01/08/2009 | CA2692253A1 Gamma secretase modulators |
| 01/08/2009 | CA2692145A1 Antiviral compounds |
| 01/07/2009 | EP2011788A1 Oxadiazolidinedione compound |
| 01/07/2009 | EP2010528A2 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling |
| 01/07/2009 | EP2010526A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands |
| 01/07/2009 | EP2010521A1 Indazole compounds and methods for inhibition of cdc7 |
| 01/07/2009 | EP2010520A1 Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases |
| 01/07/2009 | EP2010506A1 Diazepan derivatives modulators of chemokine receptors |
| 01/07/2009 | EP2010505A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 01/07/2009 | EP2010497A1 Compositions and methods for modulating gated ion channels |
| 01/07/2009 | EP2010289A2 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol |
| 01/07/2009 | EP2010168A2 Histone deacetylase inhibitors |
| 01/07/2009 | EP2009992A2 Il-8 receptor antagonists |
| 01/07/2009 | EP1928821B1 Carboxamide derivatives as muscarinic receptor antagonists |
| 01/07/2009 | EP1797042B1 Indozolone derivatives as 11b-hsd1 inhibitors |
| 01/07/2009 | EP1569916B1 Substituted aralkyl derivatives |
| 01/07/2009 | EP1562589B1 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | EP1218361B1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 01/07/2009 | EP1001939B1 Heterocyclic substituted 4-benzoyl-pyrazole as herbicides |
| 01/07/2009 | CN101341147A Substituted heterocyclic compounds with cxcr3 antagonist activity |